Identification of Tissue- and Cancer-Selective Promoters for the Introduction of Genes into Human Ovarian Cancer Cells
- 1 June 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 85 (3) , 451-458
- https://doi.org/10.1006/gyno.2002.6644
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mechanism-Based Target Identification and Drug Discovery in Cancer ResearchScience, 2000
- An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epitheliumInternational Journal of Cancer, 2000
- Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cellsBritish Journal of Cancer, 1999
- The epithelium‐specific Ets transcription factor ESX is associated with mammary gland development and involutionThe FASEB Journal, 1998
- ESX: a structurally unique Ets overexpressed early during human breast tumorigenesisOncogene, 1997
- Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells.Endocrinology, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994
- Tissue distribution of antileukoprotease and lysozyme in humans.Journal of Histochemistry & Cytochemistry, 1989
- Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase.Proceedings of the National Academy of Sciences, 1986